Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (61-70 of 379) with videos related to

Pageof 38
Sort By:
Blood|March 4, 2018
Balancing risk and benefit in early-stage classical Hodgkin lymphomaPaul J Bröckelmann, Stephanie Sasse, Andreas Engert
Oncotargets and Therapy|July 10, 2010
Expanded use of rituximab in the management of non-Hodgkin lymphomaDennis A Eichenauer, Andreas Engert, Holger Schulz
Journal of the National Cancer Institute|August 5, 2004
Biannual report of the Cochrane Haematological Malignancies GroupSven Trelle, Gail Higgins, Thilo Kober, et al.
European Journal of Haematology. Supplementum|July 13, 2005
Female fertility after cytotoxic therapy--protection of ovarian function during chemotherapy of malignant and non-malignant diseasesVerena Mattle, Karolin Behringer, Andreas Engert, et al.
Nature Clinical Practice. Oncology|March 8, 2006
Cancer-related anemia and recombinant human erythropoietin--an updated overviewJulia Bohlius, Olaf Weingart, Sven Trelle, et al.
Journal of the National Cancer Institute|April 20, 2006
Fourth biannual report of the Cochrane Haematological Malignancies GroupThilo Kober, Helge Hülsewede, Julia Bohlius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Treatment of advanced-stage hodgkin lymphoma: let us face the factsPeter Borchmann, Stefanie Kreissl, Volker Diehl, et al.
Leukemia & Lymphoma|December 15, 2005
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot studySusanne Rödel, Andreas Engert, Volker Diehl, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Monoclonal antibody-based immunotherapy of Hodgkin's lymphomaPeter Borchmann, Roland Schnell, Holger Schulz, et al.
Haematologica|December 7, 2005
Current treatment and immunotherapy of Hodgkin's lymphomaBeate Klimm, Roland Schnell, Volker Diehl, et al.
Pageof 38

Showing results (61-70 of 379) with videos related to

Sort By:
Pageof 38
Blood|March 4, 2018
Balancing risk and benefit in early-stage classical Hodgkin lymphomaPaul J Bröckelmann, Stephanie Sasse, Andreas Engert
Oncotargets and Therapy|July 10, 2010
Expanded use of rituximab in the management of non-Hodgkin lymphomaDennis A Eichenauer, Andreas Engert, Holger Schulz
Journal of the National Cancer Institute|August 5, 2004
Biannual report of the Cochrane Haematological Malignancies GroupSven Trelle, Gail Higgins, Thilo Kober, et al.
European Journal of Haematology. Supplementum|July 13, 2005
Female fertility after cytotoxic therapy--protection of ovarian function during chemotherapy of malignant and non-malignant diseasesVerena Mattle, Karolin Behringer, Andreas Engert, et al.
Nature Clinical Practice. Oncology|March 8, 2006
Cancer-related anemia and recombinant human erythropoietin--an updated overviewJulia Bohlius, Olaf Weingart, Sven Trelle, et al.
Journal of the National Cancer Institute|April 20, 2006
Fourth biannual report of the Cochrane Haematological Malignancies GroupThilo Kober, Helge Hülsewede, Julia Bohlius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Treatment of advanced-stage hodgkin lymphoma: let us face the factsPeter Borchmann, Stefanie Kreissl, Volker Diehl, et al.
Leukemia & Lymphoma|December 15, 2005
Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot studySusanne Rödel, Andreas Engert, Volker Diehl, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Monoclonal antibody-based immunotherapy of Hodgkin's lymphomaPeter Borchmann, Roland Schnell, Holger Schulz, et al.
Haematologica|December 7, 2005
Current treatment and immunotherapy of Hodgkin's lymphomaBeate Klimm, Roland Schnell, Volker Diehl, et al.
Pageof 38